We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Combining Epigenetic Therapies and Immunotherapies Improves Cancer Outcomes

News   Sep 17, 2015

 
Combining Epigenetic Therapies and Immunotherapies Improves Cancer Outcomes
 
 
 

RELATED ARTICLES

Further Calls for Diversity in Genomics Research

News

Broadening diversity among participants in human genomics research will maximize the potential of the field, say members of an international genomics consortium.

READ MORE

Improving Nature’s Own Ability To Kill Dangerous Bacteria

News

The ramifications of bacteria's ability to become resistant to antibiotics can be seen in hospitals, public places, our food supply, and our water. Now, researchers have demonstrated how we could improve upon the ability of nature's exquisitely selective collection of antimicrobial enzymes to attack bacteria in a way that's much less likely to cause bacterial resistance.

READ MORE

Viagra – The Little Blue Pill Could Reshape Bone Marrow Transplants

News

A study published today in the journal Stem Cell Reports suggests that a combination of two clinically approved drugs – Viagra and Plerixafor – efficiently and rapidly mobilizes blood stem cells from the bone marrow into the bloodstream in a mouse model. This combination therapy may offer a new approach for bone marrow transplants in humans.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE